Release Date: 18/05/15 08:27 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 374.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%